These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7665802)

  • 1. Panic disorder with or without concomitant depression 5 years after treatment: a prospective follow-up.
    Albus M; Scheibe G; Scherer J
    J Affect Disord; 1995 May; 34(2):109-15. PubMed ID: 7665802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluctuation of symptoms and social functioning in panic disorder with or without concomitant depression. A 5-year prospective follow-up.
    Albus M; Scheibe G; Scherer J
    Psychopathology; 1995; 28(5):229-34. PubMed ID: 8559945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of outcome in panic disorder: a 5-year prospective follow-up study.
    Scheibe G; Albus M
    J Affect Disord; 1996 Nov; 41(2):111-6. PubMed ID: 8961038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of panic disorder with or without concomitant depression: A 2-year prospective follow-up study.
    Albus M; Scheibe G
    Am J Psychiatry; 1993 Dec; 150(12):1878-80. PubMed ID: 8238647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
    Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy.
    Baetz M; Bowen RC
    Can J Psychiatry; 1998 Feb; 43(1):73-7. PubMed ID: 9494751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personality traits in early phases of panic disorder: implications on the presence of agoraphobia, clinical severity and short-term outcome.
    Carrera M; Herrán A; Ramírez ML; Ayestarán A; Sierra-Biddle D; Hoyuela F; Rodríguez-Cabo B; Vázquez-Barquero JL
    Acta Psychiatr Scand; 2006 Dec; 114(6):417-25. PubMed ID: 17087790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A naturalistic 6-year follow-up study of patients with panic disorder.
    Lepola U; Koponen H; Leinonen E
    Acta Psychiatr Scand; 1996 Mar; 93(3):181-3. PubMed ID: 8739663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia.
    Mavissakalian MR; Perel JM; Talbott-Green M; Sloan C
    Biol Psychiatry; 1998 Jun; 43(11):848-54. PubMed ID: 9611676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific side effects of long-term imipramine management of panic disorder.
    Mavissakalian M; Perel J; Guo S
    J Clin Psychopharmacol; 2002 Apr; 22(2):155-61. PubMed ID: 11910260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term course and outcome in panic disorder: a naturalistic follow-up study.
    Cowley DS; Flick SN; Roy-Byrne PP
    Anxiety; 1996; 2(1):13-21. PubMed ID: 9160594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting prospective episodes of depression in patients with panic disorder: a longitudinal study.
    Ball SG; Otto MW; Pollack MH; Rosenbaum JF
    J Consult Clin Psychol; 1994 Apr; 62(2):359-65. PubMed ID: 8201074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of the Panic and Agoraphobia Scale in a clinical trial.
    Bandelow B; Brunner E; Broocks A; Beinroth D; Hajak G; Pralle L; Rüther E
    Psychiatry Res; 1998 Jan; 77(1):43-9. PubMed ID: 10710174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 15-year follow-up study of patients with panic disorder.
    Andersch S; Hetta J
    Eur Psychiatry; 2003 Dec; 18(8):401-8. PubMed ID: 14680716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structure of phobias in panic disorder.
    Argyle N; Solyom C; Solyom L
    Br J Psychiatry; 1991 Sep; 159():378-82. PubMed ID: 1958949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
    Keller MB; Lavori PW; Goldenberg IM; Baker LA; Pollack MH; Sachs GS; Rosenbaum JF; Deltito JA; Leon A; Shear K
    J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DSM-III-R Axis I and II disorders in agoraphobic inpatients with and without panic disorder before and after psychosocial treatment.
    Hoffart A; Thornes K; Hedley LM
    Psychiatry Res; 1995 Jan; 56(1):1-9. PubMed ID: 7792336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coincidence of schizophrenia and panic disorder].
    Rupprecht R; Ströhle A
    Nervenarzt; 1999 Mar; 70(3):265-8. PubMed ID: 10231815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of panic disorder in a clinical setting: a 12-month naturalistic study.
    Marchesi C; Ampollini P; Signifredi R; Maggini C
    Neuropsychobiology; 1997; 36(1):25-31. PubMed ID: 9211441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Course and outcome in panic disorder: a review of recent follow-up studies.
    Roy-Byrne PP; Cowley DS
    Anxiety; 1994-1995; 1(4):151-60. PubMed ID: 9160567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.